SCHEMBL26094171

SCHEMBL26094171

O=CC(=O)C1CCC(N2Cc3c(F)c(N4CC5CCC(C4)N5)cc(F)c3C2=O)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26094421 0.96 — —
SCHEMBL26090922 0.89 HDAC1 (0.30) —
SCHEMBL26094545 0.88 — —
SCHEMBL26092014 0.86 — —
SCHEMBL26094422 0.86 MAP4K1 (0.33) —
SCHEMBL26133341 0.85 PARP1 (0.31) —
SCHEMBL26133128 0.85 MAPK1 (0.33) —
SCHEMBL26094893 0.85 — —
SCHEMBL26094320 0.84 PARP1 (0.31) —
SCHEMBL26094622 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066350-A1 CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS 标新生物医药科技(上海)有限公司 2023-04-27 — — WO claimed
Send feedback